Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : CLVLF save search
Commercial Update SCENESSE®
Published: 2023-03-08 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: -1.18%
H: 1.5%
C: -0.03%
scenesse commercial update
Relief from Quarterly Reporting
Published: 2023-03-02 (Crawled : 02:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: 1.58%
H: 0.0%
C: -0.25%
CLINUVEL launches CYACÊLLE, Next Generation Solar Care
Published: 2023-02-28 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: 3.53%
H: 0.5%
C: -0.19%
solar care
CYACÊLLE Polychromatic Solar Care – λ3
Published: 2023-02-28 (Crawled : 23:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: 3.53%
H: 0.5%
C: -0.19%
solar care
Proposed issue of Securities
Published: 2023-02-27 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: -5.85%
H: 0.0%
C: -1.0%
Appendix 4D Half Yearly Report
Published: 2023-02-23 (Crawled : 23:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: -1.6%
H: 0.0%
C: 0.0%
report
Global SCENESSE® demand drives increased CLINUVEL revenues, earnings
Published: 2023-02-23 (Crawled : 23:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: -1.6%
H: 0.0%
C: 0.0%
scenesse global
CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals
Published: 2023-02-02 (Crawled : 01:00) - globenewswire.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: 0.64%
H: 2.18%
C: 0.8%
drug skin
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population
Published: 2023-02-01 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: 0.64%
H: 2.18%
C: 0.8%
skin
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population – Technical Note
Published: 2023-02-01 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: 0.64%
H: 2.18%
C: 0.8%
skin
Appendix 4C & Activity Report
Published: 2023-01-30 (Crawled : 23:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: -7.51%
H: 0.0%
C: -5.57%
report
NEURACTHEL® manufacturing processes advance
Published: 2023-01-22 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: 0.27%
H: 4.17%
C: 1.24%
neuracthel
Afamelanotide Reduces DNA Photodamage in Xeroderma Pigmentosum
Published: 2023-01-15 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
dna
Afamelanotide Reduces DNA Photodamage in Xeroderma Pigmentosum – Technical Note
Published: 2023-01-15 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
dna
Media release: CLINUVEL Trial Results Show Drug Reduces DNA Damage
Published: 2023-01-15 (Crawled : 00:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
drug media dna trial results show
CLINUVEL Trial Results Show Drug Reduces DNA Damage
Published: 2023-01-15 (Crawled : 00:00) - globenewswire.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
drug dna trial results show
News Kommuniqué 1
Published: 2023-01-12 (Crawled : 11:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: 0.65%
H: 0.0%
C: 0.0%
News Communiqué I
Published: 2023-01-09 (Crawled : 02:00) - clinuvel.com
CLVLF | $8.9 53.4% 2K
|
Health Technology
|
| O: -1.31%
H: 0.0%
C: 0.0%
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: -3.37%
H: 0.5%
C: 0.15%
CLINUVEL Communiqué VI
Published: 2022-12-23 (Crawled : 03:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
|
| O: -1.48%
H: 5.21%
C: 5.21%
Notification of cessation of securities
Published: 2022-12-21 (Crawled : 06:00) - clinuvel.com
CLVLY | $9.756 31.84% 15K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $8.9 53.4% 2K
|
Health Technology
| Email alert
Add to watchlist
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.